Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives

Gian Eugenio Tontini, Maurizio Vecchi, Luca Pastorelli, Markus F. Neurath, Helmut Neumann

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Distinction between Crohn's disease of the colonrectum and ulcerative colitis or inflammatory bowel disease (IBD) type unclassified can be of pivotal importance for a tailored clinical management, as each entity often involves specific therapeutic strategies and prognosis. Nonetheless, no gold standard is available and the uncertainty of diagnosis may frequently lead to misclassification or repeated examinations. Hence, we have performed a literature search to address the problem of differential diagnosis in IBD colitis, revised current and emerging diagnostic tools and refined disease classification strategies. Nowadays, the differential diagnosis is an untangled issue, and the proper diagnosis cannot be reached in up to 10% of patients presenting with IBD colitis. This topic is receiving emerging attention, as medical therapies, surgical approaches and leading prognostic outcomes require more and more disease-specific strategies in IBD patients. The optimization of standard diagnostic approaches based on clinical features, biomarkers, radiology, endoscopy and histopathology appears to provide only marginal benefits. Conversely, emerging diagnostic techniques in the field of gastrointestinal endoscopy, molecular pathology, genetics, epigenetics, metabolomics and proteomics have already shown promising results. Novel advanced endoscopic imaging techniques and biomarkers can shed new light for the differential diagnosis of IBD, better reflecting diverse disease behaviors based on specific pathogenic pathways.

Original languageEnglish
Pages (from-to)21-46
Number of pages26
JournalWorld Journal of Gastroenterology
Volume21
Issue number1
DOIs
Publication statusPublished - Jan 7 2015

Fingerprint

Colitis
Inflammatory Bowel Diseases
Differential Diagnosis
Biomarkers
Gastrointestinal Endoscopy
Metabolomics
Molecular Pathology
Ulcerative Colitis
Radiology
Epigenomics
Crohn Disease
Proteomics
Endoscopy
Uncertainty
Molecular Biology
Therapeutics

Keywords

  • Advanced endoscopic imaging
  • Biomarkers
  • Crohn's disease
  • Histopathology
  • Inflammatory bowel disease unclassified
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Differential diagnosis in inflammatory bowel disease colitis : State of the art and future perspectives. / Tontini, Gian Eugenio; Vecchi, Maurizio; Pastorelli, Luca; Neurath, Markus F.; Neumann, Helmut.

In: World Journal of Gastroenterology, Vol. 21, No. 1, 07.01.2015, p. 21-46.

Research output: Contribution to journalArticle

Tontini, Gian Eugenio ; Vecchi, Maurizio ; Pastorelli, Luca ; Neurath, Markus F. ; Neumann, Helmut. / Differential diagnosis in inflammatory bowel disease colitis : State of the art and future perspectives. In: World Journal of Gastroenterology. 2015 ; Vol. 21, No. 1. pp. 21-46.
@article{f459c7ad410b4272a295fdd1b23e83df,
title = "Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives",
abstract = "Distinction between Crohn's disease of the colonrectum and ulcerative colitis or inflammatory bowel disease (IBD) type unclassified can be of pivotal importance for a tailored clinical management, as each entity often involves specific therapeutic strategies and prognosis. Nonetheless, no gold standard is available and the uncertainty of diagnosis may frequently lead to misclassification or repeated examinations. Hence, we have performed a literature search to address the problem of differential diagnosis in IBD colitis, revised current and emerging diagnostic tools and refined disease classification strategies. Nowadays, the differential diagnosis is an untangled issue, and the proper diagnosis cannot be reached in up to 10{\%} of patients presenting with IBD colitis. This topic is receiving emerging attention, as medical therapies, surgical approaches and leading prognostic outcomes require more and more disease-specific strategies in IBD patients. The optimization of standard diagnostic approaches based on clinical features, biomarkers, radiology, endoscopy and histopathology appears to provide only marginal benefits. Conversely, emerging diagnostic techniques in the field of gastrointestinal endoscopy, molecular pathology, genetics, epigenetics, metabolomics and proteomics have already shown promising results. Novel advanced endoscopic imaging techniques and biomarkers can shed new light for the differential diagnosis of IBD, better reflecting diverse disease behaviors based on specific pathogenic pathways.",
keywords = "Advanced endoscopic imaging, Biomarkers, Crohn's disease, Histopathology, Inflammatory bowel disease unclassified, Ulcerative colitis",
author = "Tontini, {Gian Eugenio} and Maurizio Vecchi and Luca Pastorelli and Neurath, {Markus F.} and Helmut Neumann",
year = "2015",
month = "1",
day = "7",
doi = "10.3748/wjg.v21.i1.21",
language = "English",
volume = "21",
pages = "21--46",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "1",

}

TY - JOUR

T1 - Differential diagnosis in inflammatory bowel disease colitis

T2 - State of the art and future perspectives

AU - Tontini, Gian Eugenio

AU - Vecchi, Maurizio

AU - Pastorelli, Luca

AU - Neurath, Markus F.

AU - Neumann, Helmut

PY - 2015/1/7

Y1 - 2015/1/7

N2 - Distinction between Crohn's disease of the colonrectum and ulcerative colitis or inflammatory bowel disease (IBD) type unclassified can be of pivotal importance for a tailored clinical management, as each entity often involves specific therapeutic strategies and prognosis. Nonetheless, no gold standard is available and the uncertainty of diagnosis may frequently lead to misclassification or repeated examinations. Hence, we have performed a literature search to address the problem of differential diagnosis in IBD colitis, revised current and emerging diagnostic tools and refined disease classification strategies. Nowadays, the differential diagnosis is an untangled issue, and the proper diagnosis cannot be reached in up to 10% of patients presenting with IBD colitis. This topic is receiving emerging attention, as medical therapies, surgical approaches and leading prognostic outcomes require more and more disease-specific strategies in IBD patients. The optimization of standard diagnostic approaches based on clinical features, biomarkers, radiology, endoscopy and histopathology appears to provide only marginal benefits. Conversely, emerging diagnostic techniques in the field of gastrointestinal endoscopy, molecular pathology, genetics, epigenetics, metabolomics and proteomics have already shown promising results. Novel advanced endoscopic imaging techniques and biomarkers can shed new light for the differential diagnosis of IBD, better reflecting diverse disease behaviors based on specific pathogenic pathways.

AB - Distinction between Crohn's disease of the colonrectum and ulcerative colitis or inflammatory bowel disease (IBD) type unclassified can be of pivotal importance for a tailored clinical management, as each entity often involves specific therapeutic strategies and prognosis. Nonetheless, no gold standard is available and the uncertainty of diagnosis may frequently lead to misclassification or repeated examinations. Hence, we have performed a literature search to address the problem of differential diagnosis in IBD colitis, revised current and emerging diagnostic tools and refined disease classification strategies. Nowadays, the differential diagnosis is an untangled issue, and the proper diagnosis cannot be reached in up to 10% of patients presenting with IBD colitis. This topic is receiving emerging attention, as medical therapies, surgical approaches and leading prognostic outcomes require more and more disease-specific strategies in IBD patients. The optimization of standard diagnostic approaches based on clinical features, biomarkers, radiology, endoscopy and histopathology appears to provide only marginal benefits. Conversely, emerging diagnostic techniques in the field of gastrointestinal endoscopy, molecular pathology, genetics, epigenetics, metabolomics and proteomics have already shown promising results. Novel advanced endoscopic imaging techniques and biomarkers can shed new light for the differential diagnosis of IBD, better reflecting diverse disease behaviors based on specific pathogenic pathways.

KW - Advanced endoscopic imaging

KW - Biomarkers

KW - Crohn's disease

KW - Histopathology

KW - Inflammatory bowel disease unclassified

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84920901942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920901942&partnerID=8YFLogxK

U2 - 10.3748/wjg.v21.i1.21

DO - 10.3748/wjg.v21.i1.21

M3 - Article

C2 - 25574078

AN - SCOPUS:84920901942

VL - 21

SP - 21

EP - 46

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 1

ER -